sebetralstat
sebetralstat is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including EKTERLY. Available dosage form: tablet.
Drug Details
- Generic Name
- sebetralstat
- Brand Names
- EKTERLY
- Application Number
- NDA219301
- Sponsor
- KalVista Pharmaceuticals Ltd
- NDC Codes
- 1
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- SEBETRALSTAT
Indications and Usage
1 INDICATIONS AND USAGE EKTERLY® is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. EKTERLY ® is a plasma kallikrein inhibitor indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. ( 1 )